Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and Sevoflurane for Orthopaedic Surgery in MCI Patients
NCT03165396Unknown
- Sponsor
- Tianjin Third Central Hospital
- Start
- Nov 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propofol and sevoflurane, sponsored by Tianjin Third Central Hospital. Primary endpoint: Apolipoprotein J at 7 days. Status: unknown.
02
Drugs
propofolsevoflurane
Beyond the preview
Go deeper on NCT03165396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03165396.